Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey

Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey

Abstract Background Magnesium sulphate (MgSO4) is the only treatment approved for fetal neuroprotection. No information on its use is available in the absence of a national registry of neonatal practices. The objective of our study was to evaluate the use of MgSO4 for fetal neuroprotection in French...

Full description

Bibliographic Details
Main Authors: Clément Chollat, Lise Le Doussal, Gaëlle de la Villéon, Delphine Provost, Stéphane Marret
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Pregnancy and Childbirth
Subjects:
Magnesium sulphate
Neuroprotection
Neonatology
Very preterm infants
National survey
Online Access:http://link.springer.com/article/10.1186/s12884-017-1489-z

Internet

http://link.springer.com/article/10.1186/s12884-017-1489-z

Similar Items